# Qiagen N.V. (QGEN)

> Source: Nexqual · https://nexqual.com/QGEN · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Qiagen N.V. (QGEN), nexqual.com/QGEN" · informational, not investment advice.

**Price:** USD 46.17 (+1.34% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 45.56 · day 45.6–46.49 · 52w 32.53–57.82 · market cap $9.53B · NYQ

## Key facts
- Analysts: Buy (mean 2.13 on a 1–5 scale) (16 analysts), mean target USD 48.13 (range 40–55).
- Total return with dividends: 1Y -3.2% vs S&P 500 +18.1%; 5Y -9.4% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD 0.62, revenue estimate $534M.

## Analysts
Consensus Buy (mean 2.13 on a 1–5 scale), 16 analysts; mean target USD 48.13 (low 40, high 55).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-14 | JP Morgan | Target raised | Overweight | $50 → $55 |
| 2026-10-06 | Barclays | Upgrade | Equal-Weight → Overweight | $40 → $55 |
| 2026-09-09 | UBS | Target lowered | Neutral | $52 → $47 |
| 2026-08-10 | Citigroup | Target raised | Neutral | $38 → $45 |
| 2026-08-07 | Barclays | Target raised | Equal-Weight | $38 → $40 |
| 2026-08-07 | JP Morgan | Target raised | Overweight | $45 → $50 |
| 2026-06-23 | Morgan Stanley | Upgrade | Equal-Weight → Overweight | $40 → $42 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -3.2% | -9.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -3.2% | -1.9% |
| Volatility (annualized) | 35.1% | 26.1% |
| Max drawdown | -41.4% (Jan 2026→May 2026) | -41.4% (Nov 2021→May 2026) |

## Peers (Diagnostics & Research)
ICLR (ICON plc) USD 175.13 +6.57% · CRL (Charles River Laboratories Inte) USD 306.24 +2.41% · GRAL (GRAIL, Inc.) USD 135.46 -3.48% · RDNT (RadNet, Inc.) USD 70.41 -1.54% · RVTY (Revvity, Inc.) USD 154.71 -0.24% · MEDP (Medpace Holdings, Inc.) USD 628.6 +3.07%

## More
Full page: https://nexqual.com/QGEN · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt